Sadaf Ghaem-Maghami
Sadaf Ghaem-Maghami
Verified email at imperial.ac.uk
Title
Cited by
Cited by
Year
Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer
SS Myatt, J Wang, LJ Monteiro, M Christian, KK Ho, L Fusi, RE Dina, ...
Cancer research 70 (1), 367-377, 2010
3642010
Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis
S Ghaem-Maghami, S Sagi, G Majeed, WP Soutter
The lancet oncology 8 (11), 985-993, 2007
2852007
Indications for caesarean section
Z Penn, S Ghaem-Maghami
Best practice & research Clinical obstetrics & gynaecology 15 (1), 1-15, 2001
1912001
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
J Kaijser, A Sayasneh, K Van Hoorde, S Ghaem-Maghami, T Bourne, ...
Human reproduction update 20 (3), 449-462, 2014
1632014
Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20.
A Du Bois, I Vergote, G Ferron, A Reuss, W Meier, S Greggi, PT Jensen, ...
Journal of Clinical Oncology 35 (15_suppl), 5501-5501, 2017
1552017
Standardized approach for imaging and measuring Cesarean section scars using ultrasonography
O Naji, Y Abdallah, AJ Bij De Vaate, A Smith, A Pexsters, C Stalder, ...
Ultrasound in obstetrics & gynecology 39 (3), 252-259, 2012
1432012
Endometrial cancer
S Saso, J Chatterjee, E Georgiou, AM Ditri, JR Smith, S Ghaem-Maghami
Bmj 343, 2011
1342011
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer
CJ Maine, NHA Aziz, J Chatterjee, C Hayford, N Brewig, L Whilding, ...
Cancer immunology, immunotherapy 63 (3), 215-224, 2014
1172014
Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis
M Arbyn, CWE Redman, F Verdoodt, M Kyrgiou, M Tzafetas, ...
The Lancet Oncology 18 (12), 1665-1679, 2017
1152017
Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells
T Goto, M Takano, A Albergaria, J Briese, KM Pomeranz, B Cloke, L Fusi, ...
Oncogene 27 (1), 9-19, 2008
1012008
Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection
PY Teo, C Yang, JL Hedrick, AC Engler, DJ Coady, S Ghaem-Maghami, ...
Biomaterials 34 (32), 7971-7979, 2013
942013
Ovarian cancer immunotherapy using PD‐L1 siRNA targeted delivery from folic acid‐functionalized polyethylenimine: strategies to enhance T cell killing
PY Teo, C Yang, LM Whilding, AC Parente‐Pereira, J Maher, AJT George, ...
Advanced healthcare materials 4 (8), 1180-1189, 2015
892015
Multicentre external validation of IOTA prediction models and RMI by operators with varied training
A Sayasneh, L Wynants, J Preisler, J Kaijser, S Johnson, C Stalder, ...
British journal of cancer 108 (12), 2448-2454, 2013
892013
Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?
SJC van der Stegen, DM Davies, S Wilkie, J Foster, JK Sosabowski, ...
The Journal of Immunology 191 (9), 4589-4598, 2013
872013
The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer
TG Hopkins, M Mura, HA Al-Ashtal, RM Lahr, N Abd-Latip, K Sweeney, ...
Nucleic acids research 44 (3), 1227-1246, 2016
832016
The surgical intelligent knife distinguishes normal, borderline and malignant gynaecological tissues using rapid evaporative ionisation mass spectrometry (REIMS)
DL Phelps, J Balog, LF Gildea, Z Bodai, A Savage, MA El-Bahrawy, ...
British journal of cancer 118 (10), 1349-1358, 2018
762018
A study of symptoms described by ovarian cancer survivors
C Stavraka, A Ford, S Ghaem-Maghami, T Crook, R Agarwal, H Gabra, ...
Gynecologic oncology 125 (1), 59-64, 2012
742012
Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor
N Brownlow, C Mol, C Hayford, S Ghaem-Maghami, NJ Dibb
Leukemia 23 (3), 590-594, 2009
732009
Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells
N Chapman-Rothe, E Curry, C Zeller, D Liber, E Stronach, H Gabra, ...
Oncogene 32 (38), 4586-4592, 2013
722013
Dynamic spectral imaging: improving colposcopy
WP Soutter, E Diakomanolis, D Lyons, S Ghaem-Maghami, T Ajala, ...
Clinical Cancer Research 15 (5), 1814-1820, 2009
702009
The system can't perform the operation now. Try again later.
Articles 1–20